OMNIBUS TRANSACTION AGREEMENTOmnibus Transaction Agreement • January 10th, 2023 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
WHEREAS, pursuant to that certain Transaction Support Agreement, dated as of December 5, 2022 (the “TSA”), among the Issuer, the Convertible Noteholders and the other parties thereto, the Issuer, the Convertible Noteholders and the other parties thereto have agreed to, among other things, consummate the transactions contemplated by the Implementation Steps Memo (as defined in the TSA), either pursuant to the terms thereof or as may be modified pursuant to the terms of the TSA (such Implementation Steps Memo, as may be so modified, the “Implementation Steps Memo”); and
OMNIBUS TRANSACTION AGREEMENT BY AND AMONG OCM Luxembourg Ileos Holdings S.à r.l., Visant Corporation and Tripolis Holdings S.à r.l. Dated as of July 25, 2014Omnibus Transaction Agreement • July 30th, 2014 • Visant Corp • Jewelry, precious metal • New York
This OMNIBUS TRANSACTION AGREEMENT (this “Agreement”), dated as of July 25, 2014, is entered into by and among: (i) OCM Luxembourg Ileos Holdings S.à r.l. (the “Ileos Investor”), (ii) Visant Corporation (the “Visant Investor” and, together with the Ileos Investor, collectively, the “Investors”), and (iii) Tripolis Holdings S.à r.l. (the “Company”). Certain terms used in this Agreement are used as defined in Section 1.1. The Investors and the Company are sometimes referred to individually as a “Party.”
